Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dow Jones Industrial Average ETF (DIA) vs Smith & Nephew plc (SNN) Price & Performance

Dow Jones Industrial Average ETFTrade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

Dow Jones Industrial Average ETF vs Smith & Nephew plc — how do they compare? Dow Jones Industrial Average ETF trades at $537.56, while Smith & Nephew plc trades at $29.69 (market cap $12.54B). The key difference: Smith & Nephew plc pays a 2.65% dividend while Dow Jones Industrial Average ETF pays none, and Dow Jones Industrial Average ETF is trading nearer its 52-week high, Smith & Nephew plc nearer its low. Which is the better fit depends on your goals.

DIASNN
52-Week High
$542.79$38.70
52-Week Low
$444.64$28.73
Market Cap
$12.54B
Sector
Health
Enterprise Value
$15.57B
Dividend Yield
2.65%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dow Jones Industrial Average ETF

DIA (SPDR Dow Jones Industrial Average ETF) trades at $538.46, showing minimal daily movement with a slight 0.1% decline. The technical outlook remains bullish with strong moving average signals, though RSI levels suggest potential overbought conditions. Recent dividend distributions highlight the fund's income-generating capabilities, with upcoming payments scheduled through mid-2026.

The ETF offers diversified exposure to Dow Jones blue-chip stocks amid positive market breadth. Key risks include market volatility and geopolitical tensions affecting broad indices. Analyst sentiment remains constructive given the fund's defensive positioning and institutional inflows into core index heavyweights.

Smith & Nephew plc

Smith & Nephew (SNN) trades at $30.08, down 0.1% with bearish technical signals. The company reported mixed Q2 2026 results with revenue growth below expectations, leading to a reduced full-year outlook. Fundamentals show strong profitability with 10.1% net margin and improving cash flow trends, though recent earnings misses have tempered sentiment.

Outlook remains cautious with analyst consensus at Hold (65% of coverage). Near-term risks include U.S. orthopedics weakness and competitive pressures, offset by robotics innovation and value-based care expansion. The stock offers stable fundamentals but faces execution challenges in key markets.

Returns comparison

Trailing returns across standard periods

About Dow Jones Industrial Average ETF

The ETF is designed to track the performance of the securities and the stocks in the Dow Jones Industrial Average Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.

Read more on DIA

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN